Science Meets Business (SMB) has started a new collaboration with the productgroep Vastgoed & Infrastructuur at the Service Bedrijf. SMB has secured access to several office and lab spaces within the Radboudumc that can be leased to (starting) entrepreneurs in Health & Life Sciences. These offices and lab spaces can be leased at attractive prices for entrepreneurs.(Future) entrepreneurs looking for offices and/or lab space within the Radboudumc are invited to contact John Schalken (firstname.lastname@example.org) and/or John van Sambeek (email@example.com). They will contact the entrepreneur swiftly to assess and align the needs and possibilities and make further arrangements.
Beside spaces within the Radboudumc, also a limited amount of space is available at the Novio Tech Campus.
Related news items
Extracellular matrix targeting of chemotherapeutic drugs15 March 2018
A recent review in the Journal of Controlled Release by René Raavé, Toin van Kuppelt and Willeke Daamen, theme Reconstructive and regenerative medicine.read more
Organize an international symposium? Be involved in the ENABLE 2019 Nijmegen event15 March 2018
For the organisation of ENABLE 2019, we are searching for a Local Organising Committee (LOC). PhD candidates and postdocs who would like to be involved in hosting the European young researcher symposium in Nijmegen 2019.read more
A personal touch of Paola de Haas15 March 2018
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Paola de Haas.read more
Dutch L’Oréal UNESCO For Women in Science fellowships 201914 March 2018
The fellowship allows excellent female scientists to boost their scientific career. Two fellowships of 25.000 euros are available to women active in the field of life sciences, who have between 3 and 10 years post-PhD academic experience (comparable to Veni/Vidi level).read more
Reduced-doze efavirenz in HIV-positive pregnant women14 March 2018
In Clinical Pharmacokinetics Stein Schalkwijk and colleagues described the feasibility to reduce the efavirenz dose in HIV-positive pregnant women to minimize treatment costs and limit toxicity.read more